|
OMB
APPROVAL
|
|
OMB
Number:
3235-0058
Expires:
April
30,
2009
Estimated
average burden
hours
per
response 2.50
|
|
SEC
FILE NUMBER
000-25277
|
|
CUSIP
NUMBER
|
|
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
|
|
o Form
10-K o Form
20-F o Form
11-K x Form
10-Q o Form
10-D o Form
N-SAR
o Form N-CSR
For
the period ended: August
31, 2007
o Transition
Report
on Form 10-K
o Transition
Report
on Form 20-F
o Transition
Report
on Form 11-K
o Transition
Report
on Form 10-Q
o Transition
Report
on Form N-SAR
For
the transition period ended:
__________________________________________________________________________________________________________________________
Read
Instruction (on back page) Before Preparing Form. Please Print or
Type.
Nothing
in this form shall be construed to imply that the Commission has
verified
any information contained herein.
__________________________________________________________________________________________________________________________
If
the notification relates to a portion of the filing checked above,
identify the Item(s) to which notification relates:
|
|
__________________________________________________________________________________________________________________________
PART
I-REGISTRANT INFORMATION
__________________________________________________________________________________________________________________________
|
||
|
|
Full
Name of Registrant:
Former
Name if Applicable:
Address
of Principal Executive Office (Street and Number):
City,
State and Zip Code:
|
Herborium
Group, Inc..
Pacific
Magtron International Corp.
3
Oak Street
Teaneck,
New Jersey 07666
|
|
__________________________________________________________________________________________________________________________
PART
II-RULES 12b-25(b) AND (c)
__________________________________________________________________________________________________________________________
If
the subject report could not be filed without unreasonable effort
or
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the
following should be completed.(Check box if
appropriate.)
|
|||
|
x
x
o
|
|
|
(a)
The reasons described in detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
(b)
The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K Form N - SAR or Form
N-CSR, or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject distribution
report on
Form 10-D, or portion thereof, will be filed on or before the fifth
calendar day following the prescribed due date; and
(c)
The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
|
|
__________________________________________________________________________________________________________________________
PART
III-NARRATIVE
__________________________________________________________________________________________________________________________
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q,
10-D, N-SAR, N-CSR or the transition report, or portion thereof,
could not
be filed within the prescribed time period.
The
Company’s independent accountants have not been able to complete the
review of the financial statements for the quarter ended August 31,
2007
and the 10-QSB within the prescribed time period.
__________________________________________________________________________________________________________________________
PART
IV-OTHER INFORMATION
__________________________________________________________________________________________________________________________
(1)
Name and telephone number of person to contact in regard to this
notification:
|
|||
|
Dr.
Agnes P. Olszewski
|
201
|
836-2424
|
|
|
||
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
|
(2)
Have all other periodic reports required under Section 13 or 15(d)
of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period
that
the registrant was required to file such report(s) been filed?
x Yes o No
If
the answer is no, identify report(s).
.
(3)
Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be
reflected by the earnings statements included in the subject report
or
portion thereof?
x Yes o No
If
so, attach an explanation of the anticipated change, both narratively
and
quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
Please
see exhibit A attached hereto.
__________________________________________________________________________________________________________________________
Herborium
Group, Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
|
| |
|
|
| Date: Ocober 15, 2007 |
By:
|
/s/ Dr. Agnes P. Olszewski |
|
Chief
Executive Officer
|
||
|
INSTRUCTION:
The form may be signed by an executive officer of the registrant
or by any
other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature.
If the
statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall
be
filed with the form.
__________________________________________________________________________________________________________________________
ATTENTION
Intentional
misstatements or omissions of fact constitute Federal Criminal Violations
(See 18 U.S.C. 1001).
__________________________________________________________________________________________________________________________
|